Go Pro
→ Your book attached (From Profits Run) (Ad)tc pixel Free KNB Stock Alerts

Kanabo Group (KNB) Competitors

Kanabo Group logo
GBX 0.22 0.00 (0.00%)
As of 06/29/2026
Compare

KNB vs. TLY, SPI, MGP, SBI, and N4P

Should you buy Kanabo Group stock or one of its competitors? MarketBeat compares Kanabo Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Kanabo Group include Totally (TLY), Spire Healthcare Group (SPI), Medica Group (MGP), Sourcebio International (SBI), and N4 Pharma (N4P). These companies are all part of the "medical" sector.

How does Kanabo Group compare to Totally?

Totally (LON:TLY) and Kanabo Group (LON:KNB) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, media sentiment, dividends, analyst recommendations, profitability and earnings.

In the previous week, Totally had 1 more articles in the media than Kanabo Group. MarketBeat recorded 1 mentions for Totally and 0 mentions for Kanabo Group. Totally's average media sentiment score of 0.75 beat Kanabo Group's score of 0.00 indicating that Totally is being referred to more favorably in the media.

Company Overall Sentiment
Totally Positive
Kanabo Group Neutral

Totally has higher revenue and earnings than Kanabo Group. Kanabo Group is trading at a lower price-to-earnings ratio than Totally, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Totally£133.05M0.00-£3.79M-£1.93N/A
Kanabo Group£1.14M1.25-£8.18M-£1.42N/A

Totally has a net margin of -2.94% compared to Kanabo Group's net margin of -892.40%. Totally's return on equity of -8.85% beat Kanabo Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Totally-2.94% -8.85% -2.42%
Kanabo Group -892.40%-80.03%-20.89%

51.3% of Totally shares are held by institutional investors. Comparatively, 3.8% of Kanabo Group shares are held by institutional investors. 13.3% of Totally shares are held by insiders. Comparatively, 24.3% of Kanabo Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Totally has a beta of 0.55, meaning that its stock price is 45% less volatile than the broader market. Comparatively, Kanabo Group has a beta of 3.04, meaning that its stock price is 204% more volatile than the broader market.

Summary

Totally beats Kanabo Group on 9 of the 13 factors compared between the two stocks.

How does Kanabo Group compare to Spire Healthcare Group?

Kanabo Group (LON:KNB) and Spire Healthcare Group (LON:SPI) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, media sentiment, risk, analyst recommendations, institutional ownership, profitability, valuation and earnings.

Kanabo Group has a beta of 3.04, indicating that its share price is 204% more volatile than the broader market. Comparatively, Spire Healthcare Group has a beta of 0.924, indicating that its share price is 8% less volatile than the broader market.

Spire Healthcare Group has a net margin of 1.04% compared to Kanabo Group's net margin of -892.40%. Spire Healthcare Group's return on equity of 2.22% beat Kanabo Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Kanabo Group-892.40% -80.03% -20.89%
Spire Healthcare Group 1.04%2.22%3.73%

Spire Healthcare Group has higher revenue and earnings than Kanabo Group. Kanabo Group is trading at a lower price-to-earnings ratio than Spire Healthcare Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kanabo Group£1.14M1.25-£8.18M-£1.42N/A
Spire Healthcare Group£1.58B0.55£28.15M£4.0054.50

Spire Healthcare Group has a consensus price target of GBX 276, indicating a potential upside of 26.61%. Given Spire Healthcare Group's stronger consensus rating and higher probable upside, analysts plainly believe Spire Healthcare Group is more favorable than Kanabo Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kanabo Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Spire Healthcare Group
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Spire Healthcare Group had 1 more articles in the media than Kanabo Group. MarketBeat recorded 1 mentions for Spire Healthcare Group and 0 mentions for Kanabo Group. Kanabo Group's average media sentiment score of 0.00 equaled Spire Healthcare Group'saverage media sentiment score.

Company Overall Sentiment
Kanabo Group Neutral
Spire Healthcare Group Neutral

3.8% of Kanabo Group shares are held by institutional investors. Comparatively, 23.5% of Spire Healthcare Group shares are held by institutional investors. 24.3% of Kanabo Group shares are held by insiders. Comparatively, 39.3% of Spire Healthcare Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Spire Healthcare Group beats Kanabo Group on 13 of the 15 factors compared between the two stocks.

How does Kanabo Group compare to Medica Group?

Medica Group (LON:MGP) and Kanabo Group (LON:KNB) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, analyst recommendations, dividends, profitability, valuation, risk and earnings.

In the previous week, Medica Group had 1 more articles in the media than Kanabo Group. MarketBeat recorded 1 mentions for Medica Group and 0 mentions for Kanabo Group. Medica Group's average media sentiment score of 0.00 equaled Kanabo Group'saverage media sentiment score.

Company Overall Sentiment
Medica Group Neutral
Kanabo Group Neutral

Medica Group has a beta of 1.1, suggesting that its stock price is 10% more volatile than the broader market. Comparatively, Kanabo Group has a beta of 3.04, suggesting that its stock price is 204% more volatile than the broader market.

Medica Group has higher revenue and earnings than Kanabo Group. Kanabo Group is trading at a lower price-to-earnings ratio than Medica Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medica Group£76.98M0.00£7.20M£0.06N/A
Kanabo Group£1.14M1.25-£8.18M-£1.42N/A

Medica Group has a net margin of 9.35% compared to Kanabo Group's net margin of -892.40%. Medica Group's return on equity of 12.42% beat Kanabo Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Medica Group9.35% 12.42% 6.62%
Kanabo Group -892.40%-80.03%-20.89%

88.4% of Medica Group shares are held by institutional investors. Comparatively, 3.8% of Kanabo Group shares are held by institutional investors. 2.9% of Medica Group shares are held by insiders. Comparatively, 24.3% of Kanabo Group shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Medica Group beats Kanabo Group on 9 of the 11 factors compared between the two stocks.

How does Kanabo Group compare to Sourcebio International?

Kanabo Group (LON:KNB) and Sourcebio International (LON:SBI) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, dividends, risk, institutional ownership, analyst recommendations and profitability.

Sourcebio International has a net margin of 0.00% compared to Kanabo Group's net margin of -892.40%. Sourcebio International's return on equity of 0.00% beat Kanabo Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Kanabo Group-892.40% -80.03% -20.89%
Sourcebio International N/A N/A N/A

3.8% of Kanabo Group shares are held by institutional investors. 24.3% of Kanabo Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Sourcebio International has higher revenue and earnings than Kanabo Group. Kanabo Group is trading at a lower price-to-earnings ratio than Sourcebio International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kanabo Group£1.14M1.25-£8.18M-£1.42N/A
Sourcebio International£75.61M0.00N/A£0.09N/A

In the previous week, Kanabo Group's average media sentiment score of 0.00 equaled Sourcebio International'saverage media sentiment score.

Company Overall Sentiment
Kanabo Group Neutral
Sourcebio International Neutral

Summary

Sourcebio International beats Kanabo Group on 6 of the 8 factors compared between the two stocks.

How does Kanabo Group compare to N4 Pharma?

N4 Pharma (LON:N4P) and Kanabo Group (LON:KNB) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, media sentiment, profitability and institutional ownership.

Kanabo Group has a net margin of -892.40% compared to N4 Pharma's net margin of -15,603.59%. Kanabo Group's return on equity of -80.03% beat N4 Pharma's return on equity.

Company Net Margins Return on Equity Return on Assets
N4 Pharma-15,603.59% -91.34% -56.00%
Kanabo Group -892.40%-80.03%-20.89%

0.2% of N4 Pharma shares are held by institutional investors. Comparatively, 3.8% of Kanabo Group shares are held by institutional investors. 22.0% of N4 Pharma shares are held by insiders. Comparatively, 24.3% of Kanabo Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

N4 Pharma has higher earnings, but lower revenue than Kanabo Group. N4 Pharma is trading at a lower price-to-earnings ratio than Kanabo Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
N4 Pharma£7.07K800.95-£1.63M-£0.24N/A
Kanabo Group£1.14M1.25-£8.18M-£1.42N/A

In the previous week, N4 Pharma's average media sentiment score of 0.00 equaled Kanabo Group'saverage media sentiment score.

Company Overall Sentiment
N4 Pharma Neutral
Kanabo Group Neutral

N4 Pharma has a beta of -0.37, meaning that its stock price is 137% less volatile than the broader market. Comparatively, Kanabo Group has a beta of 3.04, meaning that its stock price is 204% more volatile than the broader market.

Summary

Kanabo Group beats N4 Pharma on 8 of the 11 factors compared between the two stocks.

Get Kanabo Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for KNB and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KNB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KNB vs. The Competition

Export
MetricKanabo GroupMedical Care Facilities IndustryMedical SectorLON Exchange
Market Cap£1.42M£1.58B£6.79B£2.94B
Dividend YieldN/A3.69%2.66%6.15%
P/E Ratio-0.1612.8727.46366.78
Price / Sales1.2517.78582.9886,365.17
Price / Cash1.827.9048.5327.87
Price / Book0.241.8010.957.69
Net Income-£8.18M£63.03M£3.57B£5.89B
7 Day PerformanceN/A-2.07%2.58%0.27%
1 Month PerformanceN/A0.41%1.67%-1.37%
1 Year PerformanceN/A10.42%35.96%65.91%

Kanabo Group Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KNB
Kanabo Group
N/AGBX 0.23
flat		N/AN/A£1.42M£1.14MN/A20
TLY
Totally
N/AGBX 0.25
+4.2%		N/A+0.0%£491K£133.05MN/A1,668
SPI
Spire Healthcare Group
1.8584 of 5 stars		GBX 215.50
flat		GBX 276
+28.1%		-4.0%£863.29M£1.58B53.88420
MGP
Medica Group
N/AN/AN/AN/A£259.85M£76.98M3,516.671,212
SBI
Sourcebio International
N/AN/AN/AN/A£85.31M£75.61M1,277.78194

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:KNB) was last updated on 7/1/2026 by MarketBeat.com Staff.
From Our Partners
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Porter flew 3,300 miles to investigate this system
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...
Porter & Company | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Better than SpaceX? Grab this ticker instead.
Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...
Brownstone Research | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel